申请人:Guo Liangqin
公开号:US20060183904A1
公开(公告)日:2006-08-17
Certain novel N-acylated spiropiperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
某些新型N-酰化螺环吡啶衍生物是人类黑素细胞素受体的激动剂,特别是人类黑素细胞素-4受体(MC-4R)的选择性激动剂。因此,它们可用于治疗、控制或预防对MC-4R的激活有反应的疾病和障碍,如肥胖症、糖尿病、性功能障碍,包括勃起功能障碍和女性性功能障碍。